References
- Chand N. Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum. Agents Actions 1986; 19: 164–1681. Chand N. Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum. Agents Actions 1986; 19: 164–168
- Davies R. J., Lund V. J., Harten-Ash V. J. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinology 1993; 31: 159–1642. Davies R. J., Lund V. J., Harten-Ash V. J. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinology 1993; 31: 159–164
- Diamantis W. In vivo and in vitro H1 antagonist properties of azelastine. The Pharmacologist 1981; 23: 1493. Diamantis W. In vivo and in vitro H1 antagonist properties of azelastine. The Pharmacologist 1981; 23: 149
- Ebastine: a novel H1-receptor antagonist. Drugs of Today 1992; 28: 69–79, (Suppl. B)4. Ebastine: a novel H1-receptor antagonist. Drugs of Today 1992; 28: 69–79, (Suppl. B)
- Gastpar H., Aurich R., Petzold U., Vimkaes C. Azelastine nasal spray for topical treatment of allergic rhinopathy. Atemw. Lungenkrkh. Jahrgang. 1993; 19: 148–1545. Gastpar H., Aurich R., Petzold U., Vimkaes C. Azelastine nasal spray for topical treatment of allergic rhinopathy. Atemw. Lungenkrkh. Jahrgang. 1993; 19: 148–154
- McTavish D., Sorkin E. M. A review of the pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1989; 38: 778–8006. McTavish D., Sorkin E. M. A review of the pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1989; 38: 778–800